SWOG clinical trial number

SWOG-9428

Evaluation of DNA Ploidy and p53 in Patients Registered to SWOG-8794 and SWOG-9024, Ancillary

Closed

Phase

Accrual

36%

Abbreviated Title

Ancillary

Activated

05/15/1994

Closed

12/01/1999

Research committees

Genitourinary Cancer

Other Clinical Trials

SWOG Clinical Trial Number

S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"

Research Committee(s)

Genitourinary Cancer

Activated

08/14/2023

Accrual

2%

Open

Phase

SWOG Clinical Trial Number

S2200

S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2

Research Committee(s)

Genitourinary Cancer

Activated

09/19/2022

Accrual

8%

Open

Phase

SWOG Clinical Trial Number

CTSU/A031901

Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial

Research Committee(s)

Genitourinary Cancer

Activated

05/01/2021

Open

Phase